Copy link
Anesthetic Management at High Altitude
Last updated: 02/17/2026
Key Points
- High altitude reduces the partial pressure of oxygen, increasing the risk of perioperative hypoxia and complicating anesthetic management.
- Anesthetic equipment performance is affected by altitude, necessitating recalibration and verification to ensure accurate delivery of gases and anesthetic agents.
- Anesthetic management must be adapted for altitude, including careful agent selection, monitoring strategies, oxygen supplementation, and consideration of regional techniques.
Introduction
- An estimated 150 million people live above 8,200 ft (2,500 m), with even more residing above 5,000 ft (1,500 m) in regions such as the western United States, Asia, and the Andes.1
- High altitude decreases the partial pressure of oxygen in ambient air, causing hypoxemia despite a constant fractional inspired oxygen concentration, with alveolar oxygen reduced by approximately 20% at 5,500 ft (1,670 m, i.e., Denver) and 40% at 11,800 ft (3,600 m, i.e., La Paz).1
- Hypoxia at altitude triggers acclimatization, leading to physiological adaptations across respiratory, cardiovascular, and hematologic systems.
- A more detailed discussion of these physiologic changes can be found in the OpenAnesthesia summary, “Physiologic Changes at High Altitude.” Link
- High-altitude anesthesia involves the delivery of perioperative care in environments where reduced barometric pressure and hypoxia may alter physiology, monitoring, and anesthetic drug behavior.
Preoperative Evaluation and Risk Mitigation2
- The anesthesiologist should carefully assess the operative environment at altitude, as resources in remote, rural, or expedition settings may differ substantially from those in fully equipped hospital operating rooms.
- The altitude at which the procedure is being performed and the patient’s degree of acclimatization should be considered in addition to a standard preoperative evaluation.
- Descending to a lower altitude should be considered, when possible, particularly for unacclimatized patients.
- Anesthesia at very high altitude (more than 14000 ft) should be performed only when the benefits clearly outweigh the significant risks, such as in life- or limb-saving emergencies.
Inhaled Anesthetics and Vaporizers
- The physiologic effects of inhaled anesthetics are determined by their partial pressures in the alveoli and the central nervous system.
- Modern variable-bypass vaporizers maintain a nearly constant partial pressure of inhaled anesthetic regardless of altitude.1-3
- These vaporizers rely on the saturated vapor pressure of the inhaled anesthetic, which is primarily determined by temperature and largely independent of barometric pressure.2,3
- As a result, the volume of inhaled anesthetic delivered increases at higher altitudes, but the physiologic effect on the patient remains unchanged.3
- Variable-bypass vaporizers are commonly used with inhaled anesthetics such as isoflurane, sevoflurane, and halothane.
- Desflurane vaporizers, which use a measured-flow system, deliver a constant fraction of inspired anesthetic rather than a constant partial pressure. At altitude, these vaporizers produce lower partial pressures of inhaled anesthetic, requiring higher dialed concentrations to maintain equivalent anesthetic potency.1-3
- Nitrous oxide loses potency at altitude because reduced partial pressures prevent achieving clinically effective concentrations without dangerously lowering the inspired oxygen fraction.1-3
- Consequently, nitrous oxide is largely ineffective above 10,000 ft (3,048 m) and only partially effective at 5,000 ft (1,524 m).3
Anesthetic Depth and Minimum Alveolar Concentration
- Minimum alveolar concentration (MAC) is defined as the alveolar concentration of a volatile anesthetic at which 50% of patients do not move in response to a surgical stimulus, and it is commonly used to guide anesthetic depth.
- MAC is an unreliable indicator for anesthetic depth at high altitude because it is expressed as a percentage and does not reflect the partial pressure that determines physiologic effect.1-4
- Bispectral index (BIS) is a processed electroencephalography measure that continuously quantifies anesthetic hypnotic depth. BIS or similar monitoring (e.g., SedLine) is strongly recommended at high altitude to titrate volatile agents accurately, minimize overdose risk, and improve emergence and postoperative recovery.4
- One study found that over half of patients experienced deep anesthesia when measured by BIS despite being maintained at standard MAC levels.4
Gas Analyzers and Flow Meters
- Modern anesthesia machines use gas analyzers that measure the partial pressures of gases and anesthetics and convert these readings into displayed concentrations.2,3
- Gas analyzers will incorrectly display lower values at high altitude if not recalibrated.2,3
- For example, an uncalibrated oxygen analyzer will measure a concentration of 17.4% in ambient air at 5,000 ft (1,524 m), despite unchanged physiologic partial pressures.3
- Rotameter flowmeters that use a floating bobbin under-read at altitude because reduced gas density decreases bobbin lift. This leads to the displayed flow being approximately 1% lower than the delivered flow per 1,000 ft (305 m), increasing the risk of hypoxic mixtures.3
- Fixed-orifice Venturi devices will deliver higher than displayed oxygen concentrations at altitude due to reduced gas density if the flowmeters are not calibrated for altitude.2
- Flowmeter readings should be verified against partial-pressure gas analyzers after both devices have been recalibrated to the local altitude.2
General Anesthesia Considerations
- General anesthesia at high altitude will always be associated with increased risk, particularly in rural or austere operating room environments.2
- Hypoxia is the primary risk of anesthesia at altitude, and the anesthetic plan must account for altitude-related physiologic stresses, prioritizing the preservation of acclimatization responses such as tachycardia and tachypnea.2,3
- Supplemental oxygen should be utilized whenever available in the perioperative period to reduce the risk of hypoxia, with recommended minimum inspired concentrations of 30% above 5,000 ft (1,524 m) and 40% above 10,000 ft (3,048 m).2,3
- Anesthetic medications, including opioids and benzodiazepines, require careful use and titration at high altitude because hypoxia and altered ventilatory physiology can exaggerate their respiratory depressant effects.1-3
- Total intravenous anesthesia is generally considered safer than inhalational anesthesia at high altitude, but the increased risks of respiratory depression and hypoxia remain.3
- Rapid-sequence intubation and full-stomach precautions are recommended at high altitude due to delayed gastric emptying and increased aspiration risk.3
- Propofol remains a safe choice for induction but may require higher doses at altitude.3
- Maintaining normothermia is critical at high altitude, as austere or poorly equipped operating environments can increase the risk of perioperative hypothermia.3
- Thermoregulation measures include warming the operating room, using warmed IV fluids and blankets, humidifying inspired gases, and applying advanced rewarming techniques (e.g., heated peritoneal, bladder, or colonic lavage, or extracorporeal circulation) when needed.3
- Bleeding risk is increased at high altitude, potentially attributable to elevated venous pressures and higher capillary density in acclimated individuals.2
- Hypovolemia may result from inadequate fluid intake, insensible losses, impaired hemostasis, and reduced aldosterone production. Volume resuscitation should be cautious to prevent pulmonary edema, as altitude increases this risk.2
- Delayed emergence from anesthesia is more common at high altitude.2
- Postoperative opioids require cautious use at high altitude to prevent ventilatory depression.2
- Antithrombotic prophylaxis should be considered in postoperative patients due to high-altitude–induced hypercoagulability.3
Ketamine at High-Altitude
- Ketamine can provide effective anesthesia at high altitude or in austere settings without supplemental oxygen, as it preserves respiratory drive, airway reflexes, and cardiovascular stability more reliably than other agents.2,3
- Administration strategies include total intravenous ketamine or ketamine supplemented with inhaled anesthetics, selected based on available resources and anesthesiologist expertise.2
- Respiratory risks include oxygen desaturation and apnea, particularly in spontaneously breathing patients, and require close monitoring. Supplemental oxygen should be administered whenever available.2,3
- Ketamine may increase pulmonary vascular resistance and should be used cautiously in patients with active or at high risk for high-altitude pulmonary edema.2
Regional Anesthesia Considerations
- Regional and neuraxial anesthesia are generally considered safe and often advantageous at high altitude, as they preserve spontaneous ventilation and reduce the risk of perioperative hypoxia.3
- Brachial plexus and stellate ganglion blocks require caution, as potential phrenic nerve involvement can significantly impair respiratory function at high altitude. Similar caution should be applied to neuraxial anesthesia, as high blocks can also significantly affect respiratory function at altitude.3
- Spinal anesthesia maintains high efficacy at altitude and can provide effective analgesia for many lower-extremity surgeries without significant complications.2
- Regional anesthesia may exhibit slower onset and shorter duration of blocks at high altitude, potentially due to altered pharmacokinetics of local anesthetics.2
- Postdural puncture headache incidence may increase at altitude due to hypovolemia and altered cerebrospinal fluid pressure, although modern small-gauge, pencil-point needles have mitigated much of this risk.2
References
- Bebic Z, Brooks Peterson M, Polaner DM. Respiratory physiology at high altitude and considerations for pediatric patients. Paediatr Anaesth. 2022;32(2):118-125. PubMed
- Cumpstey AF, Jackson AIR, Grocott MPW. Clinical care in extreme environments: Physiology at high altitude and in space. In: Gropper MA, Eriksson LI, Fleisher LA, Cohen NH, Leslie K, Johnson-Akeju O, eds. Miller’s Anesthesia. 10th ed. Elsevier; 2024:2211-2233.e7.
- Berry JM, Camporesi E. Anesthesia at high altitude. In: Ehrenwerth J, Eisenkraft JB, Berry JM, eds. Anesthesia Equipment: Principles and Applications. 3rd ed. Saunders; 2020:468–478.
- Giraldo JC, Acosta C, Giraldo-Grueso M. Frequency of anesthetic overdose with mean alveolar concentration-guided anesthesia at high altitude. Med Gas Res. 2019;8(4):150-153. PubMed
Other References
Copyright Information

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.